Request for Proposals for Molecular Tests for STIs

This document is a Request for Proposals (RFP) issued by FIND, aimed at manufacturers of true point-of-care molecular tests for Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT). The objective is to accelerate product development and market entry for these tests in low- and middle-income countries (LMICs). The RFP outlines the need for rapid molecular diagnostic tests that adhere to existing target product profiles for primary healthcare settings. It specifies that eligible developers must possess dual NG/CT molecular assays at a technology readiness level (TRL) of 4 or above. The document details the expected project timeline, including the start of research and development activities in October 2024 and the completion of independent performance evaluations by December 2026. Additionally, it mentions co-funding opportunities for Korean applicants through collaboration with the RIGHT Foundation. The RFP emphasizes the importance of affordable pricing and operational requirements for tests used in LMICs.